| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 2.18e-07 | 15 | 73 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 5.63e-05 | 112 | 73 | 5 | GO:0090079 | |
| GeneOntologyMolecularFunction | epidermal growth factor receptor binding | 4.52e-04 | 41 | 73 | 3 | GO:0005154 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 5.53e-04 | 103 | 73 | 4 | GO:0004725 | |
| GeneOntologyBiologicalProcess | female meiosis II | 2.40e-09 | 6 | 75 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 2.40e-09 | 6 | 75 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 2.40e-09 | 6 | 75 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | oocyte development | 7.20e-08 | 99 | 75 | 7 | GO:0048599 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 9.47e-08 | 103 | 75 | 7 | GO:0009994 | |
| GeneOntologyBiologicalProcess | female gamete generation | 1.49e-06 | 223 | 75 | 8 | GO:0007292 | |
| GeneOntologyBiologicalProcess | oogenesis | 1.60e-06 | 156 | 75 | 7 | GO:0048477 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 2.27e-06 | 26 | 75 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 3.57e-06 | 29 | 75 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 4.71e-06 | 31 | 75 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | 5.44e-06 | 10 | 75 | 3 | GO:1990264 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 8.95e-06 | 77 | 75 | 5 | GO:0048255 | |
| GeneOntologyBiologicalProcess | germ cell development | 9.42e-06 | 482 | 75 | 10 | GO:0007281 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 9.72e-06 | 37 | 75 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 1.63e-05 | 87 | 75 | 5 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 1.72e-05 | 88 | 75 | 5 | GO:0043489 | |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | 2.04e-05 | 527 | 75 | 10 | GO:0022412 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 2.15e-05 | 45 | 75 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | DAZ4 ZPBP PRAMEF14 FER BBS4 DAZ1 BRINP1 PNLDC1 DAZ3 DAZ2 PRAMEF1 PRAMEF13 DICER1 B4GALT1 SOS1 | 2.15e-05 | 1194 | 75 | 15 | GO:0048609 |
| GeneOntologyBiologicalProcess | oocyte maturation | 2.55e-05 | 47 | 75 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 3.35e-05 | 101 | 75 | 5 | GO:1902369 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 3.82e-05 | 52 | 75 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | gamete generation | DAZ4 ZPBP PRAMEF14 FER BBS4 DAZ1 PNLDC1 DAZ3 DAZ2 PRAMEF1 PRAMEF13 DICER1 SOS1 | 4.85e-05 | 982 | 75 | 13 | GO:0007276 |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 6.24e-05 | 115 | 75 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | sexual reproduction | EME1 DAZ4 ZPBP PRAMEF14 FER BBS4 DAZ1 PNLDC1 DAZ3 DAZ2 PRAMEF1 PRAMEF13 DICER1 B4GALT1 SOS1 | 6.38e-05 | 1312 | 75 | 15 | GO:0019953 |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | DAZ4 ZPBP PRAMEF14 FER BBS4 DAZ1 PNLDC1 DAZ3 DAZ2 PRAMEF1 PRAMEF13 DICER1 ALOX15B B4GALT1 | 1.27e-04 | 1235 | 75 | 14 | GO:0003006 |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | 1.39e-04 | 217 | 75 | 6 | GO:0021953 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 1.61e-04 | 75 | 75 | 4 | GO:0051785 | |
| GeneOntologyBiologicalProcess | embryo development | MBTD1 MYO3A KIFBP DYNC2H1 PRAMEF14 PTPRQ PLXNA4 ITGA8 BBS4 PNLDC1 ITGA5 PRAMEF1 PRAMEF13 DICER1 SOS1 | 1.76e-04 | 1437 | 75 | 15 | GO:0009790 |
| GeneOntologyBiologicalProcess | blastocyst formation | 1.88e-04 | 78 | 75 | 4 | GO:0001825 | |
| GeneOntologyBiologicalProcess | central nervous system projection neuron axonogenesis | 2.12e-04 | 32 | 75 | 3 | GO:0021952 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 2.28e-04 | 82 | 75 | 4 | GO:0051445 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | PTPRJ ZPBP PRAMEF14 FAT3 BBS4 RNF213 PNLDC1 AMOTL2 ITGA5 NEB PRAMEF1 PRAMEF13 DCX DICER1 B4GALT1 | 2.48e-04 | 1483 | 75 | 15 | GO:0048646 |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation | 2.55e-04 | 34 | 75 | 3 | GO:0035335 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | MYO3A KIFBP PTPRJ PTPRO FAT3 PTPRQ PLXNA4 DCX DICER1 SLITRK1 CDH17 LGI1 SOS1 | 3.39e-04 | 1194 | 75 | 13 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 3.39e-04 | 91 | 75 | 4 | GO:0006446 | |
| GeneOntologyBiologicalProcess | regulation of pro-B cell differentiation | 3.60e-04 | 8 | 75 | 2 | GO:2000973 | |
| GeneOntologyBiologicalProcess | hepoxilin metabolic process | 3.60e-04 | 8 | 75 | 2 | GO:0051121 | |
| GeneOntologyBiologicalProcess | hepoxilin biosynthetic process | 3.60e-04 | 8 | 75 | 2 | GO:0051122 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 3.65e-04 | 748 | 75 | 10 | GO:0048667 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 4.33e-04 | 268 | 75 | 6 | GO:1903046 | |
| GeneOntologyBiologicalProcess | peripheral nervous system development | 4.50e-04 | 98 | 75 | 4 | GO:0007422 | |
| GeneOntologyBiologicalProcess | central nervous system neuron development | 4.67e-04 | 99 | 75 | 4 | GO:0021954 | |
| GeneOntologyBiologicalProcess | blastocyst development | 4.92e-04 | 179 | 75 | 5 | GO:0001824 | |
| GeneOntologyBiologicalProcess | central nervous system neuron axonogenesis | 5.13e-04 | 43 | 75 | 3 | GO:0021955 | |
| GeneOntologyBiologicalProcess | galactose metabolic process | 5.76e-04 | 10 | 75 | 2 | GO:0006012 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 6.79e-04 | 292 | 75 | 6 | GO:0043488 | |
| GeneOntologyBiologicalProcess | lipoxygenase pathway | 7.02e-04 | 11 | 75 | 2 | GO:0019372 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 7.23e-04 | 410 | 75 | 7 | GO:0031589 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by cadherin | 8.00e-04 | 50 | 75 | 3 | GO:0044331 | |
| GeneOntologyBiologicalProcess | regulation of lymphoid progenitor cell differentiation | 8.41e-04 | 12 | 75 | 2 | GO:1905456 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 8.96e-04 | 308 | 75 | 6 | GO:0043487 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 9.05e-04 | 118 | 75 | 4 | GO:2000243 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 9.11e-04 | 309 | 75 | 6 | GO:0061013 | |
| GeneOntologyBiologicalProcess | pro-B cell differentiation | 9.92e-04 | 13 | 75 | 2 | GO:0002328 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 1.06e-03 | 569 | 75 | 8 | GO:0034329 | |
| GeneOntologyBiologicalProcess | translational initiation | 1.37e-03 | 132 | 75 | 4 | GO:0006413 | |
| GeneOntologyBiologicalProcess | epidermis development | 1.43e-03 | 461 | 75 | 7 | GO:0008544 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | 1.72e-03 | 350 | 75 | 6 | GO:0051321 | |
| Domain | LipOase_mml | 1.94e-04 | 6 | 68 | 2 | IPR001885 | |
| Domain | LIPOXYGENASE_1 | 1.94e-04 | 6 | 68 | 2 | PS00711 | |
| Domain | LipOase_C | 1.94e-04 | 6 | 68 | 2 | IPR013819 | |
| Domain | Lipoxygenase | 1.94e-04 | 6 | 68 | 2 | PF00305 | |
| Domain | LIPOXYGENASE_3 | 1.94e-04 | 6 | 68 | 2 | PS51393 | |
| Domain | LIPOXYGENASE_2 | 1.94e-04 | 6 | 68 | 2 | PS00081 | |
| Domain | LipOase | 1.94e-04 | 6 | 68 | 2 | IPR000907 | |
| Domain | LipOase_Fe_BS | 1.94e-04 | 6 | 68 | 2 | IPR020833 | |
| Domain | LipOase_CS | 1.94e-04 | 6 | 68 | 2 | IPR020834 | |
| Domain | PTPc | 3.02e-04 | 36 | 68 | 3 | SM00194 | |
| Domain | DHC_N1 | 3.61e-04 | 8 | 68 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 3.61e-04 | 8 | 68 | 2 | IPR013594 | |
| Domain | TYR_PHOSPHATASE_PTP | 3.84e-04 | 39 | 68 | 3 | PS50055 | |
| Domain | PTPase_domain | 4.46e-04 | 41 | 68 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 4.46e-04 | 41 | 68 | 3 | PF00102 | |
| Domain | Integrin_alpha | 7.03e-04 | 11 | 68 | 2 | PF00357 | |
| Domain | FN3 | 7.90e-04 | 199 | 68 | 5 | PS50853 | |
| Domain | FN3_dom | 9.84e-04 | 209 | 68 | 5 | IPR003961 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.16e-03 | 14 | 68 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.16e-03 | 14 | 68 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.16e-03 | 14 | 68 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.16e-03 | 14 | 68 | 2 | PF08393 | |
| Domain | MT | 1.16e-03 | 14 | 68 | 2 | PF12777 | |
| Domain | AAA_8 | 1.16e-03 | 14 | 68 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.16e-03 | 14 | 68 | 2 | IPR011704 | |
| Domain | Ras_G-nucl-exch_fac_CS | 1.16e-03 | 14 | 68 | 2 | IPR019804 | |
| Domain | AAA_5 | 1.16e-03 | 14 | 68 | 2 | PF07728 | |
| Domain | PTPc_motif | 1.30e-03 | 59 | 68 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 1.30e-03 | 59 | 68 | 3 | IPR003595 | |
| Domain | DHC_fam | 1.33e-03 | 15 | 68 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.33e-03 | 15 | 68 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.33e-03 | 15 | 68 | 2 | PF03028 | |
| Domain | Integrin_alpha_C_CS | 1.52e-03 | 16 | 68 | 2 | IPR018184 | |
| Domain | AAA+_ATPase | 1.88e-03 | 144 | 68 | 4 | IPR003593 | |
| Domain | AAA | 1.88e-03 | 144 | 68 | 4 | SM00382 | |
| Domain | Integrin_alpha-2 | 1.92e-03 | 18 | 68 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 1.92e-03 | 18 | 68 | 2 | PF08441 | |
| Domain | LH2 | 1.92e-03 | 18 | 68 | 2 | SM00308 | |
| Domain | Integrin_alpha | 1.92e-03 | 18 | 68 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 1.92e-03 | 18 | 68 | 2 | PS00242 | |
| Domain | Int_alpha_beta-p | 2.15e-03 | 19 | 68 | 2 | IPR013519 | |
| Domain | PRAME_family | 2.15e-03 | 19 | 68 | 2 | IPR026271 | |
| Domain | Int_alpha | 2.15e-03 | 19 | 68 | 2 | SM00191 | |
| Domain | RasGEFN | 2.38e-03 | 20 | 68 | 2 | SM00229 | |
| Domain | Tyr_Pase_AS | 2.39e-03 | 73 | 68 | 3 | IPR016130 | |
| Domain | RasGEF_N | 2.62e-03 | 21 | 68 | 2 | PF00618 | |
| Domain | PLAT | 2.62e-03 | 21 | 68 | 2 | PS50095 | |
| Domain | - | 2.62e-03 | 21 | 68 | 2 | 2.60.60.20 | |
| Domain | PLAT | 2.62e-03 | 21 | 68 | 2 | PF01477 | |
| Domain | PLAT/LH2_dom | 2.62e-03 | 21 | 68 | 2 | IPR001024 | |
| Domain | Ras-like_Gua-exchang_fac_N | 2.88e-03 | 22 | 68 | 2 | IPR000651 | |
| Domain | FG_GAP | 2.88e-03 | 22 | 68 | 2 | PS51470 | |
| Domain | RASGEF_NTER | 2.88e-03 | 22 | 68 | 2 | PS50212 | |
| Domain | FG-GAP | 3.42e-03 | 24 | 68 | 2 | PF01839 | |
| Domain | FG-GAP | 3.42e-03 | 24 | 68 | 2 | IPR013517 | |
| Domain | Integrin_dom | 3.71e-03 | 25 | 68 | 2 | IPR032695 | |
| Domain | TYR_PHOSPHATASE_1 | 3.81e-03 | 86 | 68 | 3 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 3.93e-03 | 87 | 68 | 3 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 3.93e-03 | 87 | 68 | 3 | IPR000387 | |
| Domain | RASGEF | 4.01e-03 | 26 | 68 | 2 | PS00720 | |
| Domain | - | 4.60e-03 | 92 | 68 | 3 | 3.90.190.10 | |
| Domain | RASGEF_CAT | 4.98e-03 | 29 | 68 | 2 | PS50009 | |
| Domain | RasGEF | 5.32e-03 | 30 | 68 | 2 | PF00617 | |
| Domain | - | 5.32e-03 | 30 | 68 | 2 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 5.32e-03 | 30 | 68 | 2 | IPR023578 | |
| Domain | RASGEF_cat_dom | 5.32e-03 | 30 | 68 | 2 | IPR001895 | |
| Domain | RasGEF | 5.32e-03 | 30 | 68 | 2 | SM00147 | |
| Domain | Prot-tyrosine_phosphatase-like | 5.64e-03 | 99 | 68 | 3 | IPR029021 | |
| Domain | RRM_1 | 6.98e-03 | 208 | 68 | 4 | PF00076 | |
| Domain | - | 7.19e-03 | 35 | 68 | 2 | 3.20.20.80 | |
| Pathway | WP_OVARIAN_INFERTILITY | 8.55e-06 | 35 | 53 | 4 | MM15948 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 3.56e-04 | 37 | 53 | 3 | MM14564 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 5.14e-04 | 271 | 53 | 6 | MM15406 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 5.57e-04 | 43 | 53 | 3 | M508 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS | 6.12e-04 | 10 | 53 | 2 | M47930 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 7.07e-04 | 288 | 53 | 6 | M16864 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 7.46e-04 | 11 | 53 | 2 | MM15578 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 7.46e-04 | 11 | 53 | 2 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 7.46e-04 | 11 | 53 | 2 | M47432 | |
| Pathway | PID_KIT_PATHWAY | 9.74e-04 | 52 | 53 | 3 | M231 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 1.05e-03 | 13 | 53 | 2 | M47594 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1 | 1.05e-03 | 13 | 53 | 2 | M6322 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 1.16e-03 | 123 | 53 | 4 | MM14623 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.23e-03 | 14 | 53 | 2 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 1.23e-03 | 14 | 53 | 2 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.23e-03 | 14 | 53 | 2 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 1.23e-03 | 14 | 53 | 2 | M47390 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.23e-03 | 14 | 53 | 2 | M47378 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.23e-03 | 14 | 53 | 2 | M27858 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.23e-03 | 14 | 53 | 2 | M47488 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 1.27e-03 | 126 | 53 | 4 | M695 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 1.41e-03 | 59 | 53 | 3 | M27606 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47367 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47389 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.61e-03 | 16 | 53 | 2 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.61e-03 | 16 | 53 | 2 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 1.61e-03 | 16 | 53 | 2 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 1.61e-03 | 16 | 53 | 2 | M47804 | |
| Pathway | WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER | 1.61e-03 | 16 | 53 | 2 | M39882 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 1.61e-03 | 16 | 53 | 2 | M47483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.82e-03 | 17 | 53 | 2 | M47376 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 1.82e-03 | 17 | 53 | 2 | M27918 | |
| Pathway | WP_MALE_INFERTILITY | 2.13e-03 | 145 | 53 | 4 | M39856 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 2.28e-03 | 19 | 53 | 2 | M22005 | |
| Pubmed | 8.14e-12 | 46 | 75 | 7 | 17287250 | ||
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 1.99e-11 | 4 | 75 | 4 | 15066457 | |
| Pubmed | 1.99e-11 | 4 | 75 | 4 | 7670487 | ||
| Pubmed | 1.99e-11 | 4 | 75 | 4 | 11694340 | ||
| Pubmed | 1.99e-11 | 4 | 75 | 4 | 9321470 | ||
| Pubmed | 1.99e-11 | 4 | 75 | 4 | 19223287 | ||
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 1.99e-11 | 4 | 75 | 4 | 11095434 | |
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 1.99e-11 | 4 | 75 | 4 | 26232607 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 1.99e-11 | 4 | 75 | 4 | 11688365 | |
| Pubmed | 1.99e-11 | 4 | 75 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 1.99e-11 | 4 | 75 | 4 | 11883873 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 1.99e-11 | 4 | 75 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 1.99e-11 | 4 | 75 | 4 | 16963411 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 1.99e-11 | 4 | 75 | 4 | 12801575 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 23579190 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 9.95e-11 | 5 | 75 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 9.95e-11 | 5 | 75 | 4 | 9288969 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 20008336 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 23456578 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 9.95e-11 | 5 | 75 | 4 | 8679003 | |
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 9.95e-11 | 5 | 75 | 4 | 10903443 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 9.95e-11 | 5 | 75 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 9.95e-11 | 5 | 75 | 4 | 8845845 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 11058556 | ||
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 9.95e-11 | 5 | 75 | 4 | 17416365 | |
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 9.95e-11 | 5 | 75 | 4 | 19783541 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 22293198 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 17761180 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 9.95e-11 | 5 | 75 | 4 | 12200456 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 11514340 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 11089564 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 9.95e-11 | 5 | 75 | 4 | 22223682 | |
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 9.95e-11 | 5 | 75 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 9.95e-11 | 5 | 75 | 4 | 8968756 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 9.95e-11 | 5 | 75 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 9.95e-11 | 5 | 75 | 4 | 26411291 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 9.95e-11 | 5 | 75 | 4 | 23223451 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 34985827 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 11804965 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 9.95e-11 | 5 | 75 | 4 | 14648873 | |
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 8896558 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 9700189 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 21270429 | ||
| Pubmed | 9.95e-11 | 5 | 75 | 4 | 8661148 | ||
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 2.98e-10 | 6 | 75 | 4 | 15066460 | |
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 2.98e-10 | 6 | 75 | 4 | 18452650 | |
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 2.98e-10 | 6 | 75 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 2.98e-10 | 6 | 75 | 4 | 31355046 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 2.98e-10 | 6 | 75 | 4 | 23417416 | |
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 32170089 | ||
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 16278232 | ||
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 20157580 | ||
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 17219433 | ||
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 2.98e-10 | 6 | 75 | 4 | 26077710 | |
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 2.98e-10 | 6 | 75 | 4 | 16001084 | |
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 32962040 | ||
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 17526644 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 2.98e-10 | 6 | 75 | 4 | 1869307 | |
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 11390979 | ||
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 27632217 | ||
| Pubmed | 2.98e-10 | 6 | 75 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 2.98e-10 | 6 | 75 | 4 | 14611632 | |
| Pubmed | 6.95e-10 | 7 | 75 | 4 | 10857750 | ||
| Pubmed | 6.95e-10 | 7 | 75 | 4 | 11410654 | ||
| Pubmed | 6.95e-10 | 7 | 75 | 4 | 15081113 | ||
| Pubmed | 6.95e-10 | 7 | 75 | 4 | 22699423 | ||
| Pubmed | 6.95e-10 | 7 | 75 | 4 | 11604102 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 6.95e-10 | 7 | 75 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 6.95e-10 | 7 | 75 | 4 | 26826184 | |
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 6.95e-10 | 7 | 75 | 4 | 16946704 | |
| Pubmed | 1.39e-09 | 8 | 75 | 4 | 10951504 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 1.39e-09 | 8 | 75 | 4 | 32339196 | |
| Pubmed | 1.39e-09 | 8 | 75 | 4 | 33749946 | ||
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 1.39e-09 | 8 | 75 | 4 | 23204224 | |
| Pubmed | 1.39e-09 | 8 | 75 | 4 | 29883445 | ||
| Pubmed | 1.39e-09 | 8 | 75 | 4 | 10823932 | ||
| Pubmed | 1.39e-09 | 8 | 75 | 4 | 22621333 | ||
| Pubmed | 1.39e-09 | 8 | 75 | 4 | 32686646 | ||
| Pubmed | 1.39e-09 | 8 | 75 | 4 | 11869379 | ||
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 2.49e-09 | 9 | 75 | 4 | 16310179 | |
| Pubmed | 2.49e-09 | 9 | 75 | 4 | 20159962 | ||
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 2.49e-09 | 9 | 75 | 4 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 2.49e-09 | 9 | 75 | 4 | 19695304 | |
| Pubmed | 2.49e-09 | 9 | 75 | 4 | 28235998 | ||
| Pubmed | 3.37e-09 | 59 | 75 | 6 | 11279525 | ||
| Pubmed | 4.15e-09 | 10 | 75 | 4 | 10601091 | ||
| Pubmed | 4.15e-09 | 10 | 75 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 4.15e-09 | 10 | 75 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 4.15e-09 | 10 | 75 | 4 | 38433229 | |
| Pubmed | 4.15e-09 | 10 | 75 | 4 | 9922113 | ||
| Pubmed | 4.15e-09 | 10 | 75 | 4 | 23810942 | ||
| Pubmed | 4.15e-09 | 10 | 75 | 4 | 12837688 | ||
| Pubmed | NANOS2 suppresses the cell cycle by repressing mTORC1 activators in embryonic male germ cells. | 6.51e-09 | 11 | 75 | 4 | 34401671 | |
| Pubmed | High frequency of DAZ1/DAZ2 gene deletions in patients with severe oligozoospermia. | 9.63e-09 | 3 | 75 | 3 | 11870237 | |
| Interaction | DUSP26 interactions | 1.89e-06 | 59 | 70 | 5 | int:DUSP26 | |
| Cytoband | Yq11.223 | 1.72e-05 | 93 | 75 | 4 | Yq11.223 | |
| Cytoband | 1p36.21 | 1.55e-04 | 63 | 75 | 3 | 1p36.21 | |
| Cytoband | 17p13.1 | 9.77e-04 | 118 | 75 | 3 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 1.72e-03 | 311 | 75 | 4 | chrYq11 | |
| Cytoband | 17q21.33 | 2.07e-03 | 41 | 75 | 2 | 17q21.33 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 4.10e-07 | 21 | 54 | 4 | 813 | |
| GeneFamily | PRAME family | 4.88e-05 | 24 | 54 | 3 | 686 | |
| GeneFamily | Arachidonate lipoxygenases | 1.30e-04 | 6 | 54 | 2 | 407 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 4.73e-04 | 11 | 54 | 2 | 1168 | |
| GeneFamily | Beta 4-glycosyltransferases | 1.16e-03 | 17 | 54 | 2 | 425 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 1.30e-03 | 18 | 54 | 2 | 1160 | |
| GeneFamily | Fibronectin type III domain containing | 1.32e-03 | 160 | 54 | 4 | 555 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 3.38e-03 | 29 | 54 | 2 | 754 | |
| GeneFamily | RNA binding motif containing | 3.74e-03 | 213 | 54 | 4 | 725 | |
| GeneFamily | Nucleoporins | 4.10e-03 | 32 | 54 | 2 | 1051 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 2.85e-08 | 12 | 74 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 2.85e-08 | 12 | 74 | 4 | MM781 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 4.98e-07 | 23 | 74 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 1.74e-06 | 31 | 74 | 4 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 2.25e-06 | 33 | 74 | 4 | MM701 | |
| Coexpression | MCCABE_BOUND_BY_HOXC6 | 4.70e-05 | 461 | 74 | 8 | M6376 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500_k-means-cluster#2 | 1.90e-05 | 255 | 69 | 7 | Arv_EB-LF_500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.74e-05 | 207 | 69 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.82e-05 | 135 | 69 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k3 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.90e-05 | 433 | 69 | 8 | Arv_EB-LF_1000_K4 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.01e-06 | 162 | 75 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 180 | 75 | 5 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 181 | 75 | 5 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.41e-05 | 182 | 75 | 5 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 192 | 75 | 5 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| Drug | boron trichloride | 1.37e-09 | 6 | 72 | 4 | CID000025135 | |
| Drug | Vistar | 1.46e-09 | 36 | 72 | 6 | CID000040896 | |
| Drug | azelastine | 1.26e-07 | 74 | 72 | 6 | CID000002267 | |
| Drug | desmethylazelastine | 1.63e-07 | 16 | 72 | 4 | CID000162558 | |
| Drug | 2-chlorodideoxyadenosine | 2.41e-07 | 43 | 72 | 5 | CID000072194 | |
| Drug | dazmegrel | 3.44e-07 | 19 | 72 | 4 | CID000053555 | |
| Drug | YM 026 | 3.44e-07 | 19 | 72 | 4 | CID000004443 | |
| Drug | BW755C | 4.96e-07 | 93 | 72 | 6 | CID000047795 | |
| Drug | AZFd | 7.78e-07 | 23 | 72 | 4 | CID000196489 | |
| Drug | dansylaziridine | 7.78e-07 | 23 | 72 | 4 | CID000104008 | |
| Drug | TXB2 (thromboxane B2 | 2.02e-06 | 118 | 72 | 6 | CID000005461 | |
| Drug | d-gluconhydroximo-1,5-lactam | 2.71e-06 | 31 | 72 | 4 | CID000003479 | |
| Drug | 3-bromo-7-nitroindazole | 5.02e-06 | 36 | 72 | 4 | CID000001649 | |
| Drug | phenylbutazone | 6.58e-06 | 83 | 72 | 5 | CID000004781 | |
| Drug | molybdenum disulfide | 1.03e-05 | 43 | 72 | 4 | CID000014823 | |
| Drug | propham | 1.13e-05 | 44 | 72 | 4 | CID000024685 | |
| Drug | flurbiprofen | 1.70e-05 | 171 | 72 | 6 | CID000003394 | |
| Drug | ridogrel | 2.22e-05 | 52 | 72 | 4 | CID005362391 | |
| Drug | azafagomine | 3.20e-05 | 57 | 72 | 4 | CID011957435 | |
| Drug | AC1L2P35 | 3.33e-05 | 20 | 72 | 3 | CID000125736 | |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 3.47e-05 | 194 | 72 | 6 | 7189_UP | |
| Drug | 20-carboxyleukotriene B4 | 3.87e-05 | 21 | 72 | 3 | CID000001588 | |
| Drug | NSC56408 | 4.46e-05 | 62 | 72 | 4 | CID000005604 | |
| Drug | kt S | 5.71e-05 | 66 | 72 | 4 | CID006399216 | |
| Drug | 20-hydroxyleukotriene B4 | 7.48e-05 | 26 | 72 | 3 | CID000001589 | |
| Drug | thromboxane | 7.52e-05 | 223 | 72 | 6 | CID000114873 | |
| Drug | BW A4C | 8.40e-05 | 27 | 72 | 3 | CID006438354 | |
| Drug | p11-13 | 9.43e-05 | 75 | 72 | 4 | CID000015759 | |
| Disease | Male sterility due to Y-chromosome deletions | 2.02e-09 | 8 | 70 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 2.02e-09 | 8 | 70 | 4 | C1507149 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 7.00e-06 | 16 | 70 | 3 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 7.00e-06 | 16 | 70 | 3 | 415000 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 7.00e-06 | 16 | 70 | 3 | cv:C1839071 | |
| Disease | coronary artery disease | MBTD1 KIFBP DPP10 PTPRJ PTPRO DYNC2H1 FER RNF213 PTPRU NUP160 CDH17 SNX13 | 2.21e-05 | 1194 | 70 | 12 | EFO_0001645 |
| Disease | L lactate dehydrogenase measurement | 3.20e-05 | 26 | 70 | 3 | EFO_0004808 | |
| Disease | mental process | 3.32e-05 | 4 | 70 | 2 | EFO_0004323 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 4.96e-05 | 30 | 70 | 3 | C1868672 | |
| Disease | aspartate aminotransferase measurement | PTPRJ ZPLD1 DNAH2 RNF213 HPSE2 NUP160 SNX13 B4GALT1 SOS1 SOS2 | 5.21e-05 | 904 | 70 | 10 | EFO_0004736 |
| Disease | neutropenia, response to metamizole, Drug-induced agranulocytosis | 8.27e-05 | 6 | 70 | 2 | EFO_0010971, HP_0012235, MONDO_0001475 | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 3.01e-04 | 11 | 70 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | temporal pole volume measurement | 3.61e-04 | 12 | 70 | 2 | EFO_0010334 | |
| Disease | Headache | 4.80e-04 | 64 | 70 | 3 | HP_0002315 | |
| Disease | nervousness | 6.52e-04 | 16 | 70 | 2 | NCIT_C74532 | |
| Disease | migraine disorder, systolic blood pressure | 8.28e-04 | 18 | 70 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 9.24e-04 | 19 | 70 | 2 | C3501846 | |
| Disease | Costello syndrome (disorder) | 9.24e-04 | 19 | 70 | 2 | C0587248 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 9.24e-04 | 19 | 70 | 2 | C1843181 | |
| Disease | diet measurement, HOMA-B | 9.24e-04 | 19 | 70 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | Cardio-facio-cutaneous syndrome | 9.24e-04 | 19 | 70 | 2 | C1275081 | |
| Disease | LEOPARD Syndrome | 1.24e-03 | 22 | 70 | 2 | C0175704 | |
| Disease | antiphospholipid syndrome | 1.48e-03 | 24 | 70 | 2 | EFO_0002689 | |
| Disease | Noonan Syndrome | 1.48e-03 | 24 | 70 | 2 | C0028326 | |
| Disease | Antiglaucoma preparations and miotics use measurement | 1.74e-03 | 26 | 70 | 2 | EFO_0009944 | |
| Disease | Hypermetropia | 1.91e-03 | 103 | 70 | 3 | HP_0000540 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VPPVFLQQQQQYQYL | 251 | Q9Y2J4 | |
| VLQRQQLDYGIYVIN | 201 | P15291 | |
| NPLVNLNYAVLLYNQ | 371 | Q96RK4 | |
| YIYELNNVTPLDNLL | 376 | Q5JVX7 | |
| HLQGLQIIFPQYLQE | 226 | O60477 | |
| IQSGYEIPQLSQYLD | 191 | Q9BZP6 | |
| LPQYLDQDLYIVING | 151 | P51648 | |
| QLNYYKQEIPVQPTT | 1201 | Q9UPY3 | |
| GQVITGCQLLVYNYQ | 176 | Q13117 | |
| GQVITGCQLLVYNYQ | 176 | Q9NR90 | |
| QQYQPVVTLQKGYTI | 1041 | Q8WUJ3 | |
| GQVNPTIKLYVVNLY | 286 | Q8N608 | |
| PNELQIINIYIYPFA | 406 | Q9Y5X5 | |
| SPQLAELCYQVIYQL | 1056 | Q92621 | |
| YQSPHLLLLQGYSQQ | 246 | Q96JH8 | |
| VQYNINPYLLQSNKT | 266 | Q12913 | |
| NLPIIKNNGQVYTYP | 31 | Q05BQ5 | |
| QLVDLAPLGYNYTVN | 141 | Q86UW9 | |
| NAYLNQLLGNVIEQY | 1016 | Q6ZRQ5 | |
| IQERNQGLALPYTYL | 686 | Q9BYJ1 | |
| SQYNVLLVLETYNVP | 571 | Q9HCM2 | |
| YPGNYEQQQILIRQL | 266 | Q9H3P7 | |
| LQEQGENTYVPYILA | 526 | Q8NAT1 | |
| LVHQYLLQPYGQEGL | 521 | Q8WWQ2 | |
| EVVVYGIPYLQNLEN | 371 | Q495T6 | |
| GIPYLQNLENIIDTY | 376 | Q495T6 | |
| ESNPREVGQIYLYLQ | 351 | P53708 | |
| LGPQTLQYSYTPQLQ | 441 | Q9UHF4 | |
| LQKLLPGYYINLNQN | 151 | A2A3N6 | |
| IENLVPGAQYQVVIY | 496 | Q16827 | |
| QPNGLVFYYVSLILQ | 1121 | Q9UMZ3 | |
| QEPNGLITQYEISYQ | 511 | Q92729 | |
| YPEYLINLVQGQLQT | 246 | P08648 | |
| EQLQTIYGAYLEPVL | 2436 | Q8NCM8 | |
| GQVITGCQLLVYNYQ | 506 | Q9NQZ3 | |
| YLQYGTPNVLNEDVQ | 66 | Q9H1M3 | |
| GAQLHQNQYYDITLP | 191 | P16591 | |
| QNQYYDITLPLLLDS | 196 | P16591 | |
| VQYYQHLLQPIGPQQ | 731 | O15063 | |
| LSDNINLPQGVRYIY | 91 | O43602 | |
| LYLLNITIYDLGNPQ | 796 | Q8TDW7 | |
| IILQLNRYYPQILTN | 31 | Q96LW7 | |
| VNAYPSPQLLVQAYQ | 501 | Q96AY2 | |
| GQVITGCQLLVYNYQ | 341 | Q86SG3 | |
| QYYIGPLRISSQQIN | 2931 | Q8NDH2 | |
| PATPNGQLYYQIVIQ | 156 | Q12864 | |
| GQLYYQIVIQLPMIN | 161 | Q12864 | |
| YPVLLQNVQEYLDPT | 3436 | Q9P225 | |
| YLPNPSEVQNYAILN | 316 | Q96RP9 | |
| PLTVDLNPQYYLLVN | 456 | Q96EK5 | |
| LQNPLENLELTYGYL | 291 | Q5VWM6 | |
| IQERNQGLVLPYTYL | 651 | O15296 | |
| PLINQLSDPDYINQY | 261 | Q9Y5W8 | |
| GYVLTLSNAQPVLQY | 621 | Q86VP1 | |
| TGEIQQYQNQPYCLR | 966 | Q07890 | |
| LQNPLENLELTYGYL | 291 | Q5SWL7 | |
| IHQVVLPVLGYNIQY | 591 | Q9H0K6 | |
| QYLDVLAPYVNQVNL | 386 | Q8NA58 | |
| LQNPLENLELTYGYL | 291 | O95521 | |
| IQQYQNQPYCLRVES | 971 | Q07889 | |
| CQYVQLQDYIQLLHP | 886 | Q12769 | |
| AVPSLIYTLQNNLQY | 116 | P78381 | |
| CRDNTIQGQQVYYPI | 731 | Q70JA7 | |
| YYRLPGLEQVLNTQD | 796 | Q63HN8 | |
| VQYPNQGLQLLLKYT | 56 | P01737 | |
| LLYNDSTYNQQLIIP | 191 | Q8TCW7 | |
| LQEQLAQGVPRYSYL | 76 | Q14592 | |
| YLNVEYNAIQLILPG | 451 | Q96PX8 | |
| YYLSVLQQPTQQALL | 356 | Q96MK2 | |
| ISIQGLILVNEPYYN | 1066 | Q9C0C9 | |
| VQYPNQGLQLLLKYL | 56 | A0A0B4J262 | |
| QGLEAYIQGILYLNQ | 81 | Q96L94 | |
| YIQGILYLNQEVPKE | 86 | Q96L94 | |
| AEQLPQIYYIEGTLQ | 281 | Q9BS86 | |
| LQYYLSLLNQQLPIE | 876 | O75643 | |
| VQYLQQEYLPSLQVA | 916 | O43592 | |
| PLQINNYQYAILGSD | 481 | O95970 | |
| QIYVYVGDILIALNP | 366 | Q8NEV4 | |
| NLQNYNLVTDTPLYV | 4641 | P20929 |